Cancer, Advanced Completed Phase 1 / 2 Trials for Ramucirumab (DB05578)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

DBCOND0041606 (Cancer, Advanced)Completed1 / 2 IdentifierTitlePurposeDrugs
NCT02082210A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced CancerTreatment